Hyper Corporation

Hyper Corporation EBIT per Share

The EBIT per Share of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is 89.13 KRW. In the previous year, EBIT per Share was -64.33 KRW — a change of -238.55% (higher).

EBIT per Share

89.13KRW

YoY

-238.55%

Last updated:

EBIT per Share of Hyper Corporation is 2025 89.13 KRW. EBIT per Share of Hyper Corporation was 2024 -64.33 KRW. It decreases by -238.55% higher compared to the previous year.

The Hyper Corporation EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2016
-123.75 KRW
Jan 1, 2017
-391.26 KRW
Jan 1, 2018
-199.74 KRW
Jan 1, 2019
-73.39 KRW
Jan 1, 2020
-73.53 KRW
Jan 1, 2022
-440.43 KRW
Jan 1, 2023
-64.33 KRW
Jan 1, 2025
89.13 KRW
The Hyper Corporation EBIT per Share history
YEAREBIT per ShareYoY
89.13KRW-238.55%
-64.33KRW-85.39%
-440.43KRW+498.97%
-73.53KRW+0.19%
-73.39KRW-63.26%
-199.74KRW-48.95%
-391.26KRW+216.18%
-123.75KRW+203.30%
-40.80KRW-59.16%
-99.89KRW-80.68%
-517.02KRW+64.10%
-315.06KRW-250.50%
209.34KRW-137.57%
-557.25KRW+105.71%
-270.89KRW+178.87%
-97.14KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

EBIT per Share of Hyper Corporation is 89.13 KRW in 2025.

EBIT per Share of Hyper Corporation changed from -64.33 KRW to 89.13 KRW, representing a -238.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hyper Corporation

All Key Metrics — Hyper Corporation